CVS Health (NYSE:CVS) Upgraded to Hold at StockNews.com

StockNews.com upgraded shares of CVS Health (NYSE:CVS) from a sell rating to a hold rating in a report issued on Thursday morning.

A number of other analysts have also recently weighed in on the company. Evercore ISI upped their price target on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. Wolfe Research lifted their target price on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research note on Tuesday. TD Cowen boosted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Truist Financial raised their price target on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a report on Thursday. Finally, Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $70.28.

CVS Health Trading Up 4.9 %

Shares of CVS stock opened at $66.35 on Thursday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health has a 1 year low of $43.56 and a 1 year high of $80.75. The firm’s fifty day simple moving average is $50.71 and its 200 day simple moving average is $55.94. The firm has a market capitalization of $83.49 billion, a P/E ratio of 16.84, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, sell-side analysts predict that CVS Health will post 5.14 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. CVS Health’s payout ratio is presently 72.68%.

Institutional Trading of CVS Health

Institutional investors and hedge funds have recently made changes to their positions in the business. CANADA LIFE ASSURANCE Co lifted its stake in CVS Health by 3.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 2,115,154 shares of the pharmacy operator’s stock valued at $94,890,000 after buying an additional 69,641 shares during the period. Strategic Investment Solutions Inc. IL raised its position in shares of CVS Health by 77.2% in the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 446 shares during the period. MSH Capital Advisors LLC bought a new position in CVS Health during the 4th quarter worth approximately $218,000. Dodge & Cox grew its holdings in CVS Health by 11.2% during the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock valued at $3,147,054,000 after purchasing an additional 7,075,209 shares during the period. Finally, Jump Financial LLC increased its stake in CVS Health by 3,329.0% in the fourth quarter. Jump Financial LLC now owns 342,903 shares of the pharmacy operator’s stock valued at $15,393,000 after purchasing an additional 332,903 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.